R-FCM protocol

chemotherapy protocol consisting of rituximab, fludarabine, cyclophosphamide, and mitoxanthrone for treatment of mantle cell lymphoma

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Rituximab: 15450
        R-FCM protocol
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Rituximab: 15450
        R-FCM protocol
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Rituximab: 15450
        R-FCM protocol
Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - R-FCM protocol
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - R-FCM protocol
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - R-FCM protocol
Organic Chemicals: 133
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        Mitoxantrone: 2907
        R-FCM protocol
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        Vidarabine: 560
        R-FCM protocol
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - Vidarabine: 560
        R-FCM protocol
  - Arabinonucleosides: 1
    - Vidarabine: 560
      - R-FCM protocol